Transient gene expression mediated by integrase-defective retroviral vectors

Biochemical and Biophysical Research Communications

Volumn 368, Issue 4, 2008, Pages 942-947

  Yu, Seung Shin ^a   Dan, Kazuyuki ^a   Chono, Hideto ^a   Chatani, Emi ^a   Mineno, Junichi ^a   Kato, Ikunoshin ^b  

^a TAKARA BIO INC   (Japan)

^b Biotechnology Research Laboratories   (Japan)

Author keywords

Integrase defective; Integration; Retroviral vector; Transient expression

Indexed keywords

INTEGRASE; LUCIFERASE; RETROVIRUS VECTOR;

ARTICLE; GENE TARGETING; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; MOLONEY LEUKEMIA ONCOVIRUS; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SOUTHERN BLOTTING; TRANSIENT EXPRESSION;

ANTIGENS, CD34; DNA, VIRAL; GENE EXPRESSION; GENETIC VECTORS; HEMATOPOIETIC STEM CELLS; HUMANS; INTEGRASES; K562 CELLS; MOLONEY MURINE LEUKEMIA VIRUS; PLASMIDS; TRANSDUCTION, GENETIC;

MOLONEY MURINE LEUKEMIA VIRUS;

EID: 40049083276     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.02.012     Document Type: Article

References (15)

1. Hacein-Bey-Abina S., von Kalle C., Schmidt M., Le Deist F., Wulffraat N., McIntyre E., Radford I., Villeval J.L., Fraser C.C., Cavazzana-Calvo M., and Fischer A. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 348 (2003) 255-256
2. Vargas Jr. J., Gusella G.L., Najfeld V., Klotman M.E., and Cara A. Novel integrase-defective lentiviral episomal vectors for gene transfer. Hum. Gene Ther. 15 (2004) 361-372
3. Nightingale S.J., Hollis R.P., Pepper K.A., Petersen D., Yu X.J., Yang C., Bahner I., and Kohn D.B. Transient gene expression by nonintegrating lentiviral vectors. Mol. Ther. 13 (2006) 1121-1132
4. Saenz D.T., Loewen N., Peretz M., Whitwam T., Barraza R., Howell K.G., Holmes J.M., Good M., and Poeschla E.M. Unintegrated lentivirus DNA persistence and accessibility to expression in nondividing cells: analysis with class I integrase mutants. J. Virol. 78 (2004) 2906-2920
5. Philippe S., Sarkis C., Barkats M., Mammeri H., Ladroue C., Petit C., Mallet J., and Serguera C. Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo. Proc. Natl. Acad. Sci. USA 103 (2006) 17684-17689
6. Lai L., Liu H., Wu X., and Kappes J.C. Moloney murine leukemia virus integrase protein augments viral DNA synthesis in infected cells. J. Virol. 75 (2001) 11365-11372
7. Naldini L., Blomer U., Gallay P., Ory D., Mulligan R., Gage F.H., Verma I.M., and Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272 (1996) 263-267
8. Yu S.S., Kim J.M., and Kim S. High efficiency retroviral vectors that contain no viral coding sequences. Gene Ther. 7 (2000) 797-804
9. Schambach A., Bohne J., Chandra S., Will E., Margison G.P., Williams D.A., and Baum C. Equal potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells. Mol. Ther. 13 (2006) 391-400
10. Bunnell B.A., Metzger M., Byrne E., Morgan R.A., and Donahue R.E. Efficient in vivo marking of primary CD4+ T lymphocytes in nonhuman primates using a gibbon ape leukemia virus-derived retroviral vector. Blood 89 (1997) 1987-1995
11. Lee J.T., Yu S.S., Han E., Kim S., and Kim S. Engineering the splice acceptor for improved gene expression and viral titer in an MLV-based retroviral vector. Gene Ther. 11 (2004) 94-99
12. Brown P.O., Bowerman B., Varmus H.E., and Bishop J.M. Correct integration of retroviral DNA in vitro. Cell 49 (1987) 347-356
13. Bukrinsky M.I., Sharova N., Dempsey M.P., Stanwick T.L., Bukrinskaya A.G., Haggerty S., and Stevenson M. Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc. Natl. Acad. Sci. USA 89 (1992) 6580-6584
14. Li L., Olvera J.M., Yoder K.E., Mitchell R.S., Butler S.L., Lieber M., Martin S.L., and Bushman F.D. Role of the non-homologous DNA end joining pathway in the early steps of retroviral infection. EMBO J. 20 (2001) 3272-3281
15. Cornu T.I., and Cathomen T. Targeted genome modifications using integrase-deficient lentiviral vectors. Mol. Ther. 15 (2007) 2107-2113